AICARDI-GOUTIÈRES SYNDROME
Clinical trials for AICARDI-GOUTIÈRES SYNDROME explained in plain language.
Never miss a new study
Get alerted when new AICARDI-GOUTIÈRES SYNDROME trials appear
Sign up with your email to follow new studies for AICARDI-GOUTIÈRES SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug hope for rare childhood immune disorders
Disease control Recruiting nowThis early-stage trial tests a new medicine called IMSB301 in people with rare diseases where the immune system attacks the body. The study includes up to 6 participants aged 12 and older. The main goal is to check if the drug is safe and how it behaves in the body.
Matched conditions: AICARDI-GOUTIÈRES SYNDROME
Phase: PHASE1 • Sponsor: ImmuneSensor Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Major study launches to unravel rare genetic diseases affecting immunity and the brain
Knowledge-focused Recruiting nowThis study aims to learn more about rare genetic diseases that affect both the immune system and the nervous system. Researchers will collect medical information and samples from 1,000 participants, including patients, their relatives, and healthy volunteers. The goal is to bette…
Matched conditions: AICARDI-GOUTIÈRES SYNDROME
Sponsor: Imagine Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC